<DOC>
	<DOCNO>NCT02611310</DOCNO>
	<brief_summary>This prospective , national , multicenter , non-interventional study design enroll participant initial diagnosis unresectable LA/mBC make 6 month prior registry enrollment . These participant prospectively follow least 5 year study enrollment evaluate anti-cancer treatment . Data participant ' previous anti-cancer treatment breast cancer collect retrospectively study entry .</brief_summary>
	<brief_title>A Study Observe Treatment Patterns Outcomes Participants Saudi Arabia With Human Epidermal Growth Factor Receptor 2 ( HER2-Positive ) Unresectable Locally Advanced Metastatic Breast Cancer ( LA/mBC )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Initially diagnose HER2positive unresectable LA/mBC 6 month prior enrollment Able comply study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>